Ivascular

Ivascular company information, Employees & Contact Information

Explore related pages

Related company profiles:

The purpose of iVascular is to develop innovative advanced medical devices and therapies for the treatment of disorders of the cardiovascular system. Its staff has extensive knowledge of biopolymers, coatings, drug delivery, mechanical engineering, medicine and pharmacy. They bring together recognised experience in the development of medical devices and implants. Thanks to the know-how provided by our scientists and technicians and an appropriate investment in technology, iVascular has implemented a vertical integration project allowing it to develop, innovate and produce cardiovascular devices from basic raw materials (plastics, polymers, metals, etc.) to the final device or implant. iVascular possesses and develops its own technologies, which have made possible the vertical integration of each and every one of the processes involved in developing a device, from the earliest design stages through to final production. In this way we guarantee the highest quality standards in all our products. iVascular has a technology center with more than 1000 m² of clean rooms (ISO 7 and ISO 8) and 250 m² of R&D laboratories equipped with the most comprehensive, advanced instrumentation in the biotechnology field. Through its direct and indirect sales network, iVascular is present in more than 70 countries around the world, and is providing with full range of products for interventional cardiology and endovascular procedures. For more information about iVascular, please, visit www.ivascular.global or If you have any questions or comments, we are ready to help you out by an e-mail to info@ivascular.global

Company Details

Employees
247
Founded
-
Address
Deichelweiherweg 1, Freiburg Im Breisgau,79102,germany
Phone
+34 936 724 311
Email
in****@****.global
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Freiburg im Breisgau
Looking for a particular Ivascular employee's phone or email?

Ivascular Questions

News

Global Vascular Stents Market to reach USD 18,277.68 million - openPR.com

Global Vascular Stents Market to reach USD 18,277.68 million openPR.com

(PDF) Revised Diagnostic Criteria for Vascular Cognitive Impairment and Dementia—The VasCog-2-WSO Criteria - researchgate.net

(PDF) Revised Diagnostic Criteria for Vascular Cognitive Impairment and Dementia—The VasCog-2-WSO Criteria researchgate.net

Luminor drug-coated balloon launched in Japan - Vascular News

Luminor drug-coated balloon launched in Japan Vascular News

Electronic vascular conduit for in situ identification of hemadostenosis and thrombosis in small animals and nonhuman primates - Nature

Electronic vascular conduit for in situ identification of hemadostenosis and thrombosis in small animals and nonhuman primates Nature

WVU Heart and Vascular Institute surgeons perform first robotic TAVR explant and aortic valve replacement - WVU Medicine

WVU Heart and Vascular Institute surgeons perform first robotic TAVR explant and aortic valve replacement WVU Medicine

VANTIS VASCULAR ANNOUNCES SUPERIOR CLINICAL PERFORMANCE OF THE CROSSFAST ADVANCED DELIVERY SYSTEM IN FIRST COMMERCIAL CASES - PR Newswire

VANTIS VASCULAR ANNOUNCES SUPERIOR CLINICAL PERFORMANCE OF THE CROSSFAST ADVANCED DELIVERY SYSTEM IN FIRST COMMERCIAL CASES PR Newswire

Peripheral Vascular Devices Market to Reach USD 20.7 Billion by 2033, Fueled by Rising Cardiovascular Disorders - vocal.media

Peripheral Vascular Devices Market to Reach USD 20.7 Billion by 2033, Fueled by Rising Cardiovascular Disorders vocal.media

Vascular Stents Market Poised for Steady Growth by 2032, Driven - openPR.com

Vascular Stents Market Poised for Steady Growth by 2032, Driven openPR.com

Two-year iVolution Pro registry data presented at LINC 2025 - Vascular News

Two-year iVolution Pro registry data presented at LINC 2025 Vascular News

iVascular Launches Essential Pro Coronary Drug-coated Balloon - Diagnostic and Interventional Cardiology

iVascular Launches Essential Pro Coronary Drug-coated Balloon Diagnostic and Interventional Cardiology

Vascular Disease Devices Market Size, Share | Forecast - 2030 - Allied Market Research

Vascular Disease Devices Market Size, Share | Forecast - 2030 Allied Market Research

iVascular launches new neurovascular portfolio with four CE-marked devices - NeuroNews International

iVascular launches new neurovascular portfolio with four CE-marked devices NeuroNews International

Vascular Contractility Relies on Integrity of Progranulin Pathway: Insights Into Mitochondrial Function - American Heart Association Journals

Vascular Contractility Relies on Integrity of Progranulin Pathway: Insights Into Mitochondrial Function American Heart Association Journals

Angiogenesis, Cancer, and Vascular Aging - Frontiers

Angiogenesis, Cancer, and Vascular Aging Frontiers

Barça training with the iVascular team - Official FC Barcelona Website

Barça training with the iVascular team Official FC Barcelona Website

Peripheral Vascular Devices Market | Global Market Analysis Report - 2035 - Future Market Insights

Peripheral Vascular Devices Market | Global Market Analysis Report - 2035 Future Market Insights

Navitian Coronary Microcatheter Receives CE Mark Approval - Diagnostic and Interventional Cardiology

Navitian Coronary Microcatheter Receives CE Mark Approval Diagnostic and Interventional Cardiology

The development of tumour vascular networks - Nature

The development of tumour vascular networks Nature

Vascular Dysfunction in Diabetes and Obesity: Focus on TRP Channels - Frontiers

Vascular Dysfunction in Diabetes and Obesity: Focus on TRP Channels Frontiers

iVascular announces first data from BARISTA trial of Restorer BMS in iliac artery treatment - Vascular News

iVascular announces first data from BARISTA trial of Restorer BMS in iliac artery treatment Vascular News

iVascular SLU receives Indian clearance for peripheral products - Vascular News

iVascular SLU receives Indian clearance for peripheral products Vascular News

Future Market Insights Reveals Peripheral Vascular Devices Market Valuation of USD 8.9 Billion in 2032, with Growth Predicted at 6.6% CAGR | Future Market Insights, Inc. - Yahoo Finance

Future Market Insights Reveals Peripheral Vascular Devices Market Valuation of USD 8.9 Billion in 2032, with Growth Predicted at 6.6% CAGR | Future Market Insights, Inc. Yahoo Finance

Mechanisms of vascular dysfunction in the interleukin-10–deficient murine model of preeclampsia indicate nitric oxide dysregulation - ScienceDirect.com

Mechanisms of vascular dysfunction in the interleukin-10–deficient murine model of preeclampsia indicate nitric oxide dysregulation ScienceDirect.com

Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor - Nature

Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor Nature

Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor–Associated Hypertension and Vascular Disease - American Heart Association Journals

Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor–Associated Hypertension and Vascular Disease American Heart Association Journals

Ion channel molecular complexes in vascular smooth muscle - Frontiers

Ion channel molecular complexes in vascular smooth muscle Frontiers

iVascular receives CE mark for iCover covered stent - Vascular News

iVascular receives CE mark for iCover covered stent Vascular News

The clinical and neuroimaging differences between vascular parkinsonism and Parkinson’s disease: a case-control study - BMC Neurology

The clinical and neuroimaging differences between vascular parkinsonism and Parkinson’s disease: a case-control study BMC Neurology

Pro-angiogenic Ginsenosides F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 - Nature

Pro-angiogenic Ginsenosides F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 Nature

First results of SOL Japan highlight "extraordinary performance" of Luminor DCB in Japanese population - Vascular News

First results of SOL Japan highlight "extraordinary performance" of Luminor DCB in Japanese population Vascular News

VEGFR2 signaling drives meningeal vascular regeneration upon head injury - Nature

VEGFR2 signaling drives meningeal vascular regeneration upon head injury Nature

Luminor drug-coated balloon receives Canadian Medical Device Licence - Vascular News

Luminor drug-coated balloon receives Canadian Medical Device Licence Vascular News

3D Bioprinting of Thick Adipose Tissues with Integrated Vascular Hierarchies - Wiley

3D Bioprinting of Thick Adipose Tissues with Integrated Vascular Hierarchies Wiley

TINTIN trial subanalyses presented at LINC 2025 - Vascular News

TINTIN trial subanalyses presented at LINC 2025 Vascular News

Pathophysiology of Vascular Remodeling in Hypertension - Wiley Online Library

Pathophysiology of Vascular Remodeling in Hypertension Wiley Online Library

Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas - ScienceDirect.com

Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas ScienceDirect.com

Hypermethylation of mitochondrial DNA in vascular smooth muscle cells impairs cell contractility - Nature

Hypermethylation of mitochondrial DNA in vascular smooth muscle cells impairs cell contractility Nature

Cagent Vascular Raises $30 Million Series C Financing - Business Wire

Cagent Vascular Raises $30 Million Series C Financing Business Wire

iVascular receives CE mark approval for Luminor 18 drug-eluting balloon - Vascular News

iVascular receives CE mark approval for Luminor 18 drug-eluting balloon Vascular News

iVascular wins CE Mark for Luminor 18 DCB - MassDevice

iVascular wins CE Mark for Luminor 18 DCB MassDevice

Innova Vascular Announces Successful Early Commercial Use of Laguna Thrombectomy System™ in Patients - PR Newswire

Innova Vascular Announces Successful Early Commercial Use of Laguna Thrombectomy System™ in Patients PR Newswire

Vascular remodeling in cancer - Oncogene - Nature

Vascular remodeling in cancer - Oncogene Nature

Kevin Mani - Vascular News

Kevin Mani Vascular News

Ten years of anti-vascular endothelial growth factor therapy - Nature

Ten years of anti-vascular endothelial growth factor therapy Nature

Endothelial damage, vascular bagging and remodeling of the microvascular bed in human microangiopathy with deep white matter lesions - Acta Neuropathologica Communications

Endothelial damage, vascular bagging and remodeling of the microvascular bed in human microangiopathy with deep white matter lesions Acta Neuropathologica Communications

Identification of Tp0751 (Pallilysin) as a Treponema pallidum Vascular Adhesin by Heterologous Expression in the Lyme disease Spirochete - Nature

Identification of Tp0751 (Pallilysin) as a Treponema pallidum Vascular Adhesin by Heterologous Expression in the Lyme disease Spirochete Nature

Angiolite BTK below-the-knee sirolimus-eluting stent receives CE mark approval - Vascular News

Angiolite BTK below-the-knee sirolimus-eluting stent receives CE mark approval Vascular News

Health P.E.I. reveals plan to improve vascular services - CBC

Health P.E.I. reveals plan to improve vascular services CBC

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant